Former top legal executives at large companies including Microsoft, Intel and Eli Lilly submitted a legal brief on Tuesday ...

The criticism is an early sign that the economic tumult caused by Trump’s trade war could leave lasting political scars for ...

That's why Veeva Systems should remain a leader in its niche and deliver excellent returns over the long run. It's a top stock to buy and hold for the next two decades.

This is CNBC’s coverage of how U.S. trade partners, industries and employers respond to President Donald Trump’s historic tariffs.

This is CNBC’s coverage of how U.S. trade partners, industries and employers respond to President Donald Trump’s historic ...

The New York Times reported that drugmakers are preparing for tariffs specifically targeting pharmaceuticals, with levies potentially hitting 25 percent or higher. Trump has repeatedly vowed to enact ...

Investing.com -- Eli Lilly and Company (NYSE: LLY) CEO David Ricks spoke to the BBC about the long-term effects of the Trump administration’s sweeping tariffs on imports, in the first comments from a ...

But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in ...

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Shares of Sangamo Therapeutics Inc (NASDAQ: SGMO) surged 30.2% following the announcement of a significant licensing agreement with pharmaceutical giant Eli Lilly and Company (NYSE: LLY ). The deal ...

LillyDirect will help provide services to millions of patients who have yet to be formally diagnosed with the disease.

Eli Lilly is developing a groundbreaking drug, lepodisiran, to combat high LPA cholesterol levels prevalent in South Asians, ...